- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana CEO Catarina Löwenadler interviewed by Redeye
Dignitana CEO Catarina Löwenadler was interviewed by Redeye analyst Mats Hyttinge highlighting Dignitana's continued growth as published in the Q3 Interim Report titled "19% growth and cost reduction creates another quarter of positive EBITDA."
Watch the video interview in Swedish here: Dignitana: interview with CEO Catarina Löwenadler.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, firstname.lastname@example.org +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.